Competition for Cholesterol Players

September 30, 2019

Competition for Cholesterol Players

The Medicines Company (MDCO) recently reported top-line pivotal data on its siRNA candidate inclisiran, which targets the PCSK9 (proprotein convertase subtilisin/kexin type 9) pathway for lowering cholesterol. According to MDCO, inclisiran reduces levels of LDL cholesterol with just two injections annually. As a premium courier, Yourway functions as the backbone of the supply chain, allowing new therapies to reach patients more efficiently.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?